Publications: Gut Microbiota Composition (20)
2023
Gravdal K, Kirste KH, Grzelak K, Kirubakaran GT, Leissner P, Saliou A, Casèn C. Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study - PubMed (nih.gov). BMC Endocr Disord. 2023 Aug 21;23(1):179. doi: 10.1186/s12902-023-01432-0. PMID: 37605183; PMCID: PMC10440924.
2022
Telle-Hansen VH, Gaundal L, Bastani N, Rud I, Byfuglien MG, Gjøvaag T, Retterstøl K, Holven KB, Ulven SM, Myhrstad MCW. Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels-a randomized controlled trial in healthy individuals - PubMed (nih.gov). Lipids Health Dis. 2022 Sep 26;21(1):92. doi: 10.1186/s12944-022-01702-1. PMID: 36163070.
Gaundal L, Myhrstad MCW, Rud I, Gjøvaag T, Byfuglien MG, Retterstøl K, Holven KB, Ulven SM, Telle-Hansen VH. Gut microbiota is associated with dietary intake and metabolic markers in healthy individuals - PubMed (nih.gov) Food Nutr Res. 2022 Jun 23;66. doi: 10.29219/fnr.v66.8580. PMID: 35844956; PMCID: PMC9250133.
Kumar A, Gravdal K, Segal JP, Steed H, Brookes MJ, Al-Hassi HO. Variability in the Pre-Analytical Stages Influences Microbiome Laboratory Analyses - PubMed (nih.gov) Genes (Basel). 2022 Jun 15;13(6):1069. doi: 10.3390/genes13061069. PMID: 35741831; PMCID: PMC9223004.
2021
Vasapolli R, Schulz C, Schweden M, Casèn C, Kirubakaran GT, Kirste KH, Macke L, Link A, Schütte K, Malfertheiner P. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID) - PubMed (nih.gov). Eur J Clin Invest. 2021 Aug 14:e13666. doi: 10.1111/eci.13666. Epub ahead of print. PMID: 34390492.
Ahluwalia B, Iribarren C, Magnusson MK, Sundin J, Clevers E, Savolainen O, Ross AB, Törnblom H, Simrén M, Öhman LA Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome - PubMed (nih.gov). Cells. 2021 Jun 10;10(6):1459. doi: 10.3390/cells10061459. PMID: 34200772; PMCID: PMC8230381.
Öhman L, Lasson A, Strömbeck A, Isaksson S, Hesselmar M, Simrén M, Strid H, Magnusson MK. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis - PubMed (nih.gov). Sci Rep. 2021 Apr 21;11(1):8641. doi: 10.1038/s41598-021-87973-7. PMID: 33883600; PMCID: PMC8060394.
2020
Bratlie M, Hagen IV, Helland A, Erchinger F, Midttun Ø, Ueland PM, Rosenlund G, Sveier H, Mellgren G, Hausken T, Gudbrandsen OA. Effects of high intake of cod or salmon on gut microbiota profile, faecal output and serum concentrations of lipids and bile acids in overweight adults: a randomised clinical trial - PubMed (nih.gov). Eur J Nutr. 2020 Oct 27.
Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C, Lindquist CM, Söderholm JD, Gomollón F, Kalla R, Satsangi J, Vatn MH, Jahnsen J, Halfvarson J, Ricanek P; Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character) - PubMed (nih.gov). Scand J Gastroenterol. 2020 Oct;55(10).
Berentsen B, Nagaraja BH, Teige EP, Lied GA, Lundervold AJ, Lundervold K, Steinsvik EK, Hillestad ER, Valeur J, Brønstad I, Gilja OH, Osnes B, Hatlebakk JG, Haász J, Labus J, Gupta A, Mayer EA, Benitez-Páez A, Sanz Y, Lundervold A, Hausken T. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome - PubMed (nih.gov). Medicine (Baltimore). 2020 Sep 11;99(37):e21950. doi: 10.1097/MD.0000000000021950. PMID: 32925728; PMCID: PMC7489588.
2019
Klingberg E, Magnusson MK, Strid H, et al. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin - PubMed (nih.gov). Arthritis Res Ther. 2019;21(1):248. Published 2019 Nov 27.
Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome - PubMed (nih.gov). Clin Exp Gastroenterol. 2019;12:37-49. Published 2019 Jan 31.
2018
Mazzawi T, Lied GA, Sangnes DA, et al The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation - PubMed (nih.gov). PLoS One. 2018;13(11):e0194904. Published 2018 Nov 14.
Bennet SMP, Böhn L, Störsrud S, et al. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs - PubMed (nih.gov). Gut. 2018;67(5):872-881.
Valeur J, Småstuen MC, Knudsen T, Lied GA, Røseth AG. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome - PubMed (nih.gov). Dig Dis Sci. 2018;63(2):429-436.
2016
Vebø HC, Karlsson MK, Avershina E, Finnby L, Rudi K. Bead-beating artefacts in the Bacteroidetes to Firmicutes ratio of the human stool metagenome - PubMed (nih.gov). J Microbiol Methods. 2016;129:78-80.
Magnusson MK, Strid H, Sapnara M, et al. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition - PubMed (nih.gov). J Crohns Colitis. 2016;10(8):943-952.
2015
Casén C, Vebø HC, Sekelja M, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD - PubMed (nih.gov). Aliment Pharmacol Ther. 2015;42(1):71-83.
2013
Thorkildsen LT, Nwosu FC, Avershina E, et al. Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients - PubMed (nih.gov). Gastroenterol Res Pract. 2013;2013:636785.
2011
Vebø HC, Sekelja M, Nestestog R, et al. Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant array - PubMed (nih.gov). Clin Vaccine Immunol. 2011;18(8):1326-1335.